neoplasm
• about 18% of assessable tumor cases develop an acinar-cell carcinoma component of pancreatic tumors
|
• high penetrance (29 of 30 mutants) of pancreatic ductal adenocarcinomas
|
mortality/aging
• average survival time is 84 days, with a range of 48-110 days
|
endocrine/exocrine glands
• about 18% of assessable tumor cases develop an acinar-cell carcinoma component of pancreatic tumors
|
• high penetrance (29 of 30 mutants) of pancreatic ductal adenocarcinomas
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
pancreatic carcinoma | DOID:4905 |
OMIM:260350 |
J:166678 |